What is the α/β ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy
G.M Duschesne L.J Peters What is the α/β ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy Int J Radiat Oncol Biol Phys 44 1999 747 748
Optimization of conformal radiation treatment of prostate cancer: Report of a dose-escalation study
G.E Hanks T.E Schultheiss A.L Hanlon Optimization of conformal radiation treatment of prostate cancer Report of a dose-escalation study Int J Radiat Oncol Biol Phys 37 1997 543 550
Pinover WH, Hanlon AL, Horowitz EM; et al. Defining the Appropriate Dose for Prostate Cancer Patients with PSA < 10 ng/ml. Proceedings of the 40th ASTRO Annual Meeting, Phoenix, AZ, 1998.
6
0027136115
Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor
A Niemierko M Goitein Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor Radiother Oncol 29 1993 140 147
Radiation inactivation of human prostate cancer cells: The role of apoptosis
O Algan C.C Stobbe A.M Helt G.E Hanks J.D Chapman Radiation inactivation of human prostate cancer cells The role of apoptosis Radiat Res 146 1996 267 275
Radiobiological studies of PC-3 and DU-145 human prostate cancer cells: X-ray sensitivity in vitro and hypoxic fractions of xenografted tumors in vivo
J.T Leith L Quaranto G Padfield S Michelson A Hercbergs Radiobiological studies of PC-3 and DU-145 human prostate cancer cells X-ray sensitivity in vitro and hypoxic fractions of xenografted tumors in vivo Int J Radiat Oncol Biol Phys 25 1993 283 287